Pryor Cashman Music Litigation Team Earns Shout Out In Am Law LOTW List – Music and the Arts



To print this article, all you need is to be registered or login on Mondaq.com.

1271916a.jpg

A team of Pryor Cashman litigators—led by Benjamin Semel,
Frank Scibilia, and Donald Zakarin, along with Mona Simonian,
Kaveri Arora, Marion Harris, and Joshua Weigensberg—earned a
“Shout Out” in The American Lawyer Litigation
Daily’s
“Litigator of the Week” column for their
exceptional work representing the National Music Publishers’
Association (NMPA) and the Nashville Songwriters Association
International (NSAI).

The team from the firm’s renowned Music + Entertainment
Litigation Group led the litigation on behalf of NMPA and NSAI from
inception through its historic settlement just days before trial
was set to begin, resolving one of the largest litigations in the
U.S. music industry’s history.

The Am Law column notes, “At the end of last year,
the U.S. Copyright Royalty Board adopted a settlement that raises
the statutory ‘mechanical’ royalty rates paid by
interactive streaming services such as Spotify and Apple Music. The
settlement, which went into effect at the turn of the year, sets
the rate at 15.1% of streaming revenues for 2023 and raises it over
a five-year period to 15.35% in 2027.”

Read the full article using the link below (subscription
required).

Resources

The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.

POPULAR ARTICLES ON: Media, Telecoms, IT, Entertainment from United States

2023 Top Privacy Issues: New Laws & Expanded Enforcement

Global Advertising Lawyers Alliance (GALA)

Privacy laws and enforcement will see some big changes in 2023. Last year brought more state laws and regulations, as well as FTC and GDPR developments — and that focus on privacy is expected…

FTC Issues New Guidance For Health Claims

Frankfurt Kurnit Klein & Selz

Making health claims? And who isn’t? If you are, you should be sure to read the FTC’s new Health Products Compliance Guidance. Or at least this blog post…

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top
%d bloggers like this: